Arturo Molina

机构：Protagonist Therapeutics (United States) · ORCID：0009-0008-0161-5775

发表论文 218 篇 · 总被引 21660 次 · h-index 56

代表论文

• Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials (2017 · Journal of Clinical Oncology · 被引 233)
• Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone (2019 · European Urology · 被引 87)
• Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera (2024 · New England Journal of Medicine · 被引 56)
• Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001 (2018 · Oncotarget · 被引 53)
• High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti‐CD74‐drug conjugate (2018 · The Journal of Pathology Clinical Research · 被引 44)
• Investigational Antibody–Drug Conjugates for Treatment of B-lineage Malignancies (2018 · Clinical Lymphoma Myeloma & Leukemia · 被引 37)